Battle to acquire GlaxoSmithKline’s Horlicks has started

Livemint has reported today that Switzerland-based Nestlé, US-based   Kraft Heinz and Unilever and India-based ITC are the potential buyers of GlaxoSmithKline’s Horlicks asset. Horlicks is one of the most important of GSK’s brands and is likely to be sold for $2.2bn, that is 4x 2017 sales; however, Reuters has reported that the division is likely to easily reach $4bn.

(Source: Livemint)